Business · 23/07/2003

FDA's Drug Safety and Risk Management Advisory Committee to Review and Revise Drug Safety Notice

The US Food and Drug Administration's (FDA) Drug Safety and Risk Management Advisory Committee will review and revise the agency's drug safety notice, following a request from the public to update the guidance.